Betoptic (soln)
| Betoptic (soln) | |
|---|---|
| DOSAGE | 1-2 gtts BID |
| GENERIC | Betaxolol HCI 0.25%, 0.5% |
| SIZE | 5mL, 10 mL, 15 mL |
| INDICATIONS | Reduction of elevated intraocular pressure (IOP) |
| MECHANISM OF ACTION | Selective B1 receptor blocker |
| MICROBIOLOGY | The predominant mechanism of ocular hypotensive action of topical beta-adrenergic blocking agents is likely due to a reduction in aqueous humor production. |
| CONTRAINDICATIONS & WARNINGS | Hypersensitivity to any component of this product. BETOPTIC Ophthalmic Solution is contraindicated in patients with sinus bradycardia, greater than a first degree atrioventricular block, cardiogenic shock, or patients with overt cardiac failure. |
| PEDIATRIC USE | Safety and effectiveness in pediatric patients have not been established. |
| PREGNANCY | There are no adequate and well-controlled studies in pregnant women. |
| NOTE | Betoptic S is the suspension (Shake well before use) |